Form 4: Ventyx Biosciences Director Somu Subramaniam Reports Share Distribution

Director Somu Subramaniam reports the distribution of shares from NSV Investments III, L.P. and indirect beneficial ownership of Ventyx Biosciences, Inc. shares.

Summary

• On April 12, 2024, Somu Subramaniam, a director of Ventyx Biosciences, Inc., reported a transaction involving the distribution of 695,339 common stock shares from NSV Investments III, L.P.
• The shares were distributed to limited partners on a pro rata basis for no consideration.
• Following the transaction, Subramaniam's indirect beneficial ownership amounts to 7,744,296 shares.
• These shares are held through various entities including NSV Investments I, L.P., NSV Investments III, L.P., NSV Partners III, L.P., New Science Ventures, LLC, NSV Partners II, LLC, and NSV Investments II, L.P.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders, such as directors and officers, in their company's stock.

Stakeholder Impact

• Shareholders are informed about changes in ownership by company insiders.
• The filing ensures transparency and compliance with SEC regulations.

Key Dates